MEIS2 dels/dups# | MEIS2 mutations& | Patient A# | Patient H# | II-2; II-3 | I-1 | |
---|---|---|---|---|---|---|
Mutation size/coordinates$ | Variable | SNVs and indels | 194 Kb/chr15:36989551_37184183 | 2.92 Mb/chr15:34308789_37231638 | 423 Kb/chr15: chr15:36808211-37231497 | |
Non-mosaic | Mosaic | |||||
Mutation types | Disruption including exon 9* | 7 nonsense; 6 missense; 3 splicing; 2 in-frame del; 2 frameshift mutation | Exon 12 deletion* | Exon 10–12 deletion* | Exon 10–12 deletion* | |
Inheritance Mode | 19 de novo; 2 familial;8 NA | 18 de novo/2 pat | de novo | de novo | pat | de novo |
Palate defects | 22/26; 1 NA | 16/20 | − | − | Bifid uvula | − |
Cardiac defects | 10/26; 1 NA | 13/18; 2 NA | − | − | − | ASD |
Developmental delay | + | + | + | + | Mild | − |
Walked@ | 14mo-4y | 18mo (Giliberti et al. 2020); 26mo (11 cases reviewed in Verheije et al., 2019); 30mo (Santoro et al. 2021); 32mo (Su et al. 2020); NA (6 cases from Srivastava et al. 2018, Hildebrand et al. 2020, Douglas et al. 2018) | 27mo | 30mo | II-2: 18mo; II-3: 21mo | − |
Facial features | Variable: 10/12 (14 cases from Verheije et al. 2019) | Variable; 17/17; 3 NA | − | Anteverted nares, asymmetric ears with abnormal helix | − | − |
Intellectual disability | 19/21; 8 NA | 20/20 | + | + | NA | − |